SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007088
Filing Date
2021-05-13
Accepted
2021-05-13 16:31:44
Documents
50
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ewt-20210331x10q.htm   iXBRL 10-Q 1711699
2 EX-10.1 ewt-20210331xex10d1.htm EX-10.1 41827
3 EX-31.1 ewt-20210331xex31d1.htm EX-31.1 17274
4 EX-31.2 ewt-20210331xex31d2.htm EX-31.2 17548
5 EX-32.1 ewt-20210331xex32d1.htm EX-32.1 12624
6 GRAPHIC ewt-20210331xex10d1001.jpg GRAPHIC 8041
  Complete submission text file 0001558370-21-007088.txt   5122655

Data Files

Seq Description Document Type Size
7 EX-101.SCH ewt-20210331.xsd EX-101.SCH 28323
8 EX-101.CAL ewt-20210331_cal.xml EX-101.CAL 27013
9 EX-101.DEF ewt-20210331_def.xml EX-101.DEF 121179
10 EX-101.LAB ewt-20210331_lab.xml EX-101.LAB 296541
11 EX-101.PRE ewt-20210331_pre.xml EX-101.PRE 220696
12 EXTRACTED XBRL INSTANCE DOCUMENT ewt-20210331x10q_htm.xml XML 671669
Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40236 | Film No.: 21920138
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences